Skip to main content

Table 2 Global and regional results; all patients (n = 28)

From: Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study

   Baseline 6 months
   mBMC controls p-value 1 mBMC controls p-value 2
Left ventricle
N = 28
EDV - ml 175.1 ± 48.7 176.8 ± 52.8 0.932 174.9 ± 60.0 174.3 ± 62.3 0.828
  ESV - ml 91.2 ± 35.2 84.9 ± 41.0 0.668 87.6 ± 44.9 78.0 ± 42.3 0.674
  EF - % 49.3 ± 9.5 54.1 ± 11.3 0.233 52.4 ± 11.9 57.9 ± 10.1 0.610
  LV mass - g 168.6 ± 28.3 171.5 ± 42.1 0.831 162.4 ± 30.8 160.4 ± 41.1* 0.379
  infarct mass - g 38.6 ± 23.3 45.7 ± 29.5 0.484 37.6 ± 20.5 35.7 ± 20.4* 0.034
  infarct percent - % 22.1 ± 12.4 26.4 ± 14.8 0.410 22.2 ± 10.8 22.0 ± 11.0* 0.026
  global strain - % -11.1 ± 2.4 -11.9 ± 3.4 0.512 -11.1 ± 2.6 -13.1 ± 2.4* 0.027
  twist - ° 11.3 ± 3.6 12.8 ± 5.4 0.365 12.6 ± 4.3 11.8 ± 3.7 0.411
Infarct zone
N = 27
mass - g 103.0 ± 39.6 103.9 ± 37.6 0.955 100.3 ± 39.9 96.2 ± 34.5* 0.217
  infarct mass - g 38.6 ± 23.3 45.7 ± 29.5 0.484 37.6 ± 20.5 35.7 ± 20.4* 0.034
  infarct percent - % 34.4 ± 13.6 41.5 ± 17.7 0.242 34.3 ± 12.6 35.0 ± 11.6* 0.084
  strain - % -9.7 ± 3.4 -9.3 ± 4.1 0.770 -10.2 ± 3.3 -11.8 ± 3.0* 0.009
Transmural infarct zone
N = 13
mass - g 32.3 ± 22.6 35.0 ± 26.2 0.855 33.7 ± 21.4 33.6 ± 24.0 0.519
  infarct mass - g 29.0 ± 23.0 32.5 ± 25.2 0.804 26.6 ± 17.7 26.1 ± 19.5 0.468
  infarct percent - % 86.8 ± 7.4 90.3 ± 6.1 0.377 77.6 ± 4.3* 76.6 ± 11.4* 0.401
  strain - % -2.0 ± 1.5 -6.6 ± 5.6 0.107 -2.4 ± 1.4 -8.6 ± 4.9 0.108
Remote segments
N = 27
mass - g 64.4 ± 22.1 66.5 ± 24.3 0.816 61.1 ± 22.8 63.2 ± 24.0 0.965
  strain - % -14.4 ± 2.4 -14.9 ± 2.3 0.560 -14.3 ± 3.3 -15.6 ± 2.3 0.195
  1. p-value 1 refers to between group differences at baseline (two sample t-test). p-value 2 refers to between group differences in changes from baseline (analysis of covariance). *p < 0.05 for intra-group changes from baseline, evaluated by paired sample t-test.